tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CNTB Stock Latest News

Connect Biopharma Welcomes New Finance VP
Company AnnouncementsConnect Biopharma Welcomes New Finance VP
14d ago
6K
CNTB
Connect Biopharma Pivots to U.S. Market Strategy
PremiumCompany Announcements
Connect Biopharma Pivots to U.S. Market Strategy
16d ago
6K
CNTB
Connect Biopharma reports 1H net income $7.6M vs. net loss ($30.5M) 1H last year
PremiumThe Fly
Connect Biopharma reports 1H net income $7.6M vs. net loss ($30.5M) 1H last year
16d ago
CNTB
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
PremiumPress Releases
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
16d ago
CNTB
Connect Biopharma Executives Transition to New Roles
PremiumCompany Announcements
Connect Biopharma Executives Transition to New Roles
2M ago
6K
CNTB
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum
PremiumPress ReleasesConnect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum
3M ago
CNTB
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
Connect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
3M ago
CNTB
Connect Biopharma Unveils New Incentive Award Plan
Premium
Company Announcements
Connect Biopharma Unveils New Incentive Award Plan
3M ago
6K
CNTB
Connect Biopharma appoints Barry Quart CEO, Xanthopoulos appointed Chair
PremiumThe Fly
Connect Biopharma appoints Barry Quart CEO, Xanthopoulos appointed Chair
3M ago
CNTB
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
PremiumPress Releases
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
3M ago
CNTB
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
PremiumPress Releases
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
4M ago
CNTB
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
PremiumPress Releases
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
5M ago
CNTB
Connect Biopharma price target raised to $8 from $7 at H.C. Wainwright
PremiumThe FlyConnect Biopharma price target raised to $8 from $7 at H.C. Wainwright
5M ago
CNTB
Connect Biopharma Triumphs with Rademikibart Trials
Premium
Company Announcements
Connect Biopharma Triumphs with Rademikibart Trials
5M ago
6K
CNTB
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
Premium
Press Releases
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
5M ago
CNTB
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
PremiumPress Releases
Connect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual Conference
6M ago
CNTB
Connect Biopharma initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Connect Biopharma initiated with a Buy at H.C. Wainwright
7M ago
CNTB
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
PremiumPress Releases
Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors
7M ago
CNTB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
PFE
ACAD
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
9M ago
MOR
ACHV
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
MOR
BPMC
Connect Biopharma’s rademikibart shows efficacy and safety in Phase 2b trial
Premium
The Fly
Connect Biopharma’s rademikibart shows efficacy and safety in Phase 2b trial
9M ago
CNTB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >